Short Implant Versus Crestal Standard Length Implant to Retain Class 1 Removable Partial Denture.

Launched by MENOUFIA UNIVERSITY · Oct 29, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating the effectiveness of two types of dental implants used to support a removable partial denture (RPD) for people who have lost some teeth, particularly in the lower jaw. The trial compares short implants, which are placed slightly below the gum line, with standard-length implants that are positioned at the top of the bone. The main goal is to see which type of implant works better in terms of survival rates and overall outcomes for patients with certain bone conditions.

To be eligible for the study, participants need to be adults aged 50 or older who have lost at least one lower back tooth and are experiencing issues with their current dentures. They must have enough bone structure for the implants and no serious health issues that would prevent them from receiving implants. During the trial, participants will receive either a short or standard implant and will be monitored to assess how well the implants perform over time. This study is currently recruiting participants, and it aims to provide valuable insights for improving dental care for people with missing teeth.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria
• • adult patients aged 50 years or older with class 1 RPD with missing mandibular molars at least and complaining from instability of the prosthesis were recruited.
• • Medical history revealed no contraindication to implant therapy.
• • Patients have an amount of bone nearly equal to 8 mm length above the inferior alveolar canal to receive a 6 mm short implant with 2 mm subcrestal to the bone level with sufficient bone width ≥ 8mm on one side and an amount of bone equal to or more than 8 mm to receive a standard-length implant of 7.5, 9, or 10.5 mm placed at crestal bone level with sufficient bone width ≥ 8mm on the contralateral side which was examined by CBCT.
• Exclusion Criteria:
• • Presence of active infection or inflammation in the areas intended for implant placement; \*systemic diseases such as diabetes.
• • Pregnant and lactating patients.
• • Habit of severe bruxism or clenching.
• • Treatment with therapeutic radiation to the head within the past 12 months.
• • Treatment with bisphosphonate within the past 12 months.
• • More than 10 cigarettes/day smoking habit.